NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
DIY Brain Stimulation: Popularity Is Growing, But Is It Safe or Effective?
DIY brain stimulation, such as transcranial direct current stimulation (tDCS), is gaining popularity as a method to boost cognitive function [...]
Long-Term Cognitive Monitoring Needed After First Stroke
A recent study emphasizes the need for long-term cognitive monitoring after a person experiences their first stroke. Cognitive decline following [...]
Treatment-Resistant Depression Linked to Increased Mortality Risk
A new study has found that individuals with treatment-resistant depression (TRD) face a significantly higher risk of mortality compared to [...]
New Treatment for Non-Relapsing Secondary Progressive Multiple Sclerosis (SPMS)
A groundbreaking development in the treatment of multiple sclerosis (MS) has emerged, offering hope for those living with non-relapsing secondary [...]
Van Gogh’s Neurological and Psychiatric Conditions: What Could Have Affected the Famous Artist?
Vincent van Gogh’s life has long fascinated art lovers and medical professionals alike, especially when it comes to the neurological [...]
Understanding the Impact of Hurricanes on Neurological Health
Hurricanes and tropical storms are not just weather events—they can profoundly affect our health, particularly for individuals with neurological conditions. [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social